Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Controversies in Aggressive NHL"'
Autor:
Anita Kumar
Publikováno v:
Hematology Am Soc Hematol Educ Program
Up-front autologous stem cell transplantation (ASCT) is the established standard of care for younger, transplant-eligible MCL patients and is associated with a prolonged progression-free survival (PFS) benefit. However, there is no randomized control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f422c8e34dfced56109d0b010c3e67e4
https://europepmc.org/articles/PMC9820454/
https://europepmc.org/articles/PMC9820454/
Publikováno v:
Hematology Am Soc Hematol Educ Program
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy worldwide, comprising approximately 30% of all lymphomas. Currently, 50% to 60% of patients diagnosed with DLBCL are alive at 5 years and cured with modern therapy, but abou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a042fe7b3338c1a63932cbf076ed4ba
https://pubmed.ncbi.nlm.nih.gov/36485076
https://pubmed.ncbi.nlm.nih.gov/36485076
Publikováno v:
Hematology Am Soc Hematol Educ Program
The prevention of central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) continues to be one of the most contentious areas of lymphoma management. Outcomes for patients with secondary CNS lymphoma (SCNSL) have historically been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::076234492d5bd0cd785a55def3f0312f
https://pubmed.ncbi.nlm.nih.gov/36485105
https://pubmed.ncbi.nlm.nih.gov/36485105